港股异动 | 宝济药业-B(02659)早盘涨超7% 注射用KJ103拟纳入优先审评

智通财经
May 13

智通财经APP获悉,宝济药业-B(02659)早盘涨超7%,截至发稿,涨6.99%,报29.4港元,成交额8606.39万港元。

消息面上,5月12日,CDE官网显示,宝济药业注射用KJ103拟纳入优先审评,适用于高度致敏的肾移植患者进行脱敏治疗,有效清除预存HLA抗体预防超急性排斥反应。

据介绍,KJ103是一款全球首创、低免疫原性的重组免疫球蛋白G(IgG)降解酶,用于治疗由病理性IgG抗体介导的多种免疫性疾病。该产品通过特异性切割并降解血液循环中的病理性IgG抗体,抑制免疫应答激活,为抗体介导的自身免疫性疾病提供了靶向、快速的治疗新选择。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10